Tafasitamab Biosimilar - Ultra Low Endotoxin

Tafasitamab Biosimilar - Ultra Low Endotoxin, Human IgG1 (S239D/K274Q/Y296F/Y300F/L309V/I332E/A339T/V397M)-Kappa

Target: CD19

Specificity: Detects human CD19

Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Background: Uses the same sequence as the therapeutic antibody Tafasitamab

Concentration: 5mg/ml

Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.

Purity: ≥95% monomer by analytical SEC, >95% by SDS Page

Endotoxin: <0.1EU/mg Determined by LAL gel clotting assay

Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.

• SKU: ICH5132UL-20mg
• Manufacturer: Ichorbio
• Manufacturer SKU: ICH5132UL-20mg
• Package Unit: 20mg
• Quantity Unit: STK
• Reactivity: Human
• Clonality: Monoclonal
• Application: Functional Assay
• Isotype: Human IgG1 (S239D/K274Q/Y296F/Y300F/L309V/I332E/A339T/V397M)-Kappa